Skip to content
ContactContact

In pharmaceutical manufacturing, “dead spots” (also called stagnant zones) are areas inside a powder blender where material doesn’t move, doesn’t exchange, or moves far less than the rest of the blend. They’re one of the fastest routes to blend non-uniformity, out-of-spec content uniformity, segregation issues, and painful investigations during validation or audit.

Below are the most common causes of dead spots, how to recognise them, and what to do about them.

What is a “dead spot” in powder blending?

A dead spot is any region where powder experiences low shear, low turnover, and limited particle exchange relative to the “active” mixing volume. In practice, it often means:

In GMP environments, dead spots are not just a performance issue — they’re a process risk.

What causes dead spots inside powder blenders?

Incorrect fill level for the blender’s working volume
One of the most common causes is simply running a blender too full or too empty.

In both cases, you can end up with zones that are effectively isolated.

Blender geometry and internals that don’t promote turnover
Dead spots are often driven by how the blender moves material, especially at:

A blender can look “mixed” from the outside while still creating low-exchange pockets internally.

Powder properties that encourage bridging, caking, or cohesive flow
Pharma powders aren’t all free-flowing. Dead spots become more likely when powders are:

If the material naturally forms agglomerates, “inactive” zones can develop even in a good blender.

Inappropriate mixing speed, time, or energy input
Dead spots can be created by running a process that doesn’t match the material:

“More mixing” doesn’t always fix dead spots — sometimes it makes uniformity worse.

Poor loading sequence and minor-ingredient addition method
If low-dose APIs or excipients are added in a way that promotes localised concentration, you can create pockets that take far too long to disperse.

Common triggers include:

Build-up on internal surfaces
Dead spots can be “created” over time by:

A zone that was active during FAT/SAT can become stagnant later without obvious external signs.

Discharge design and end-of-batch behaviour
Some dead spots only reveal themselves during:

If powder consistently remains behind, it’s a sign of geometry/flow-path issues — and it can become a contamination or cross-batch risk depending on cleaning strategy.

How to tell if you have dead spots
Look for patterns like:

If you only sample from “easy” points, dead spots can stay hidden until validation or audit sampling becomes more stringent.

Practical ways to reduce or eliminate dead spots
Confirm you’re operating in the blender’s true working range (not just nominal capacity)
Review loading sequence and dosing method for minor ingredients
Assess powder behaviour: cohesion, moisture, electrostatics, PSD, density
Optimise speed/time based on material response, not habit
Consider blender features that improve exchange and turnover (geometry, internals, controlled intensification where appropriate)
Validate with a robust sampling plan that includes high-risk zones, not only convenient points

Why this matters in GMP and audit environments
Dead spots increase the risk of:

In other words: dead spots can become both a quality risk and a business risk.

How Terriva supports pharmaceutical manufacturers globally
Terriva supports pharmaceutical manufacturers with a practical, engineering-led approach: helping teams understand whether a problem is driven by equipment behaviour, powder behaviour, or process settings — and then resolving it with changes that stand up to validation and audit scrutiny.

With Terriva’s global reach, we support customers and partners across multiple regions and regulatory environments, helping standardise blending and powder-handling practices for consistent results site-to-site.

If you’re seeing inconsistent blend uniformity and suspect stagnant zones, we can help you diagnose the root cause and identify the most reliable path to a robust, audit-ready blending process.

Share This Article facebook linkedin
Close